Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy. - 72/2023 - Foreign Trade Policy

Ministry of Commerce Industry Department of Commerce Directorate General of Foreign Trade Vanijya Bhawan, New Delhi Notification No. 7 2 /2023 New Delhi, Dated: 11th March, 2024 Subject: Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy. S.O. 1249 (E) - In exercise of powers conferred by Section 3 read with section 5 of the Foreign Trade (Development Regulation) Act, 1992 (No. 22 of 1992) . as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy. 2023 , the Central Government hereby amends Export Policy under chapter 30 related to Human Biological Samples, as under: HS Code Item Description Revised Export Policy Revised Policy Condition 30021020 Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes Free subject to NOC 1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs Cosmetics Act 1940 Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR. 30021091 Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes 30021210 For diphtheria 30021220 For tetanus 30021230 For rabies 30021240 For snake venom 30021290 Other 30029010 Human Blood 2. Effect of the Notification: Export Policy of Human Biological Samples under Chapter 30 of ITC HS schedule-2 of export policy is amended to the extent that export of item that contains Human biological materials/samples/products under chapter 30 is free subject to the NOC from Central Drugs Standard Control Organization (CDSCO) or Indian Council of Medical Research (ICMR). Department of Health Research (DHR). (Santosh Kumar Sarangi) Director General of Foreign Trade Ex-Officio Additional Secretary, Government of India E-mail: [email protected] [Issued from F. No. 01/91/191/48/AM23/EC/e-35188]